SCOPUS 정보 검색 플랫폼

Volumn 16, Issue 1, 1997, Pages 101-102

Ifosfamide

Author keywords

[No Author keywords available]

Indexed keywords

IFOSFAMIDE; ALKYLATING AGENT;

CLINICAL TRIAL; HUMAN; LETTER; LUNG CANCER; PRIORITY JOURNAL; MESOTHELIOMA; NOTE;

ANTINEOPLASTIC AGENTS, ALKYLATING; HUMANS; IFOSFAMIDE; MESOTHELIOMA;

EID: 0030342018 PISSN: 01695002 EISSN: None Source Type: Journal
DOI: 10.1016/S0169-5002(96)00619-8 Document Type: Letter

Times cited : (7)

References (4)

1
- 0030249788
- Two dose levels of ifosfamide in malignant mesothelioma
- F Icli H Karaoguz S Hastürk B Kurt H Akbulut D Dincol A Demirkazik F Cay S Akyar Two dose levels of ifosfamide in malignant mesothelioma Lung Cancer 15 1996 207 213
- (1996) Lung Cancer , vol.15 , pp. 207-213
- Icli, F¹ Karaoguz, H² Hastürk, S³ Kurt, B⁴ Akbulut, H⁵ Dincol, D⁶ Demirkazik, A⁷ Cay, F⁸ Akyar, S⁹

2
- 0019818820
- Statistical contributions of phase II trials in cancer: Interpretation, analysis and design
- Y Jack RA Wealey Statistical contributions of phase II trials in cancer: Interpretation, analysis and design Semin Oncol 8 4 1981 403 416
- (1981) Semin Oncol , vol.8 , Issue.4 , pp. 403-416
- Jack, Y¹ Wealey, RA²

3
- 0025895674
- Chemotherapy in malignant mesothelioma: a review
- A Krarup-Hansen HH Hansen Chemotherapy in malignant mesothelioma: a review Cancer Chemother Pharmacol 28 1991 319 330
- (1991) Cancer Chemother Pharmacol , vol.28 , pp. 319-330
- Krarup-Hansen, A¹ Hansen, HH²

4
- 0028170021
- Phase II trials of malignant mesothelioma: a commentary and update
- A Krarup-Hansen Phase II trials of malignant mesothelioma: a commentary and update Lung Cancer 11 1994 305 308
- (1994) Lung Cancer , vol.11 , pp. 305-308
- Krarup-Hansen, A¹

* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.